Amneal Pharmaceuticals (AMRX) Prepaid Assets (2017 - 2026)

Amneal Pharmaceuticals has reported Prepaid Assets for 10 years, with the latest figure at $112.0 million in Q2 2026.

• On a quarterly basis, Prepaid Assets rose 31.31% year-over-year to $112.0 million in Q2 2026; TTM through Jun 2026 was $112.0 million, a 31.31% increase from a year earlier, with the FY2025 full-year figure at $98.4 million, up 21.9% from the prior year.
• Prepaid Assets was $112.0 million for Q2 2026 at Amneal Pharmaceuticals, up from $103.1 million in the prior quarter.
• The five-year high for Prepaid Assets was $232.2 million in Q2 2022, with the low at $80.7 million in Q4 2024.
• Average Prepaid Assets over 5 years is $103.6 million, with a median of $90.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Prepaid Assets surged 123.71% in 2022, then sank 64.79% in 2023.
• Over 5 years, Prepaid Assets stood at $103.6 million in 2022, then retreated by 20.16% to $82.7 million in 2023, then decreased by 2.38% to $80.7 million in 2024, then climbed by 21.9% to $98.4 million in 2025, then grew by 13.84% to $112.0 million in 2026.
• The last three Prepaid Assets figures came in at $112.0 million (Q2 2026), $103.1 million (Q1 2026), and $98.4 million (Q4 2025), per Business Quant data.